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High‑resolution analyses of human sperm
dynamic methylome reveal thousands of novel
age‑related epigenetic alterations
Mingju Cao1†, Xiaojian Shao2,3,4†, Peter Chan5, Warren Cheung6, Tony Kwan2,3, Tomi Pastinen2,3,6†
and Bernard Robaire1,7*†

Abstract
Background: Children of aged fathers are at a higher risk of developing mental disorders. Alterations in sperm DNA
methylation have been implicated as a potential cause. However, age-dependent modifications of the germ cells’
epigenome remain poorly understood. Our objective was to assess the DNA methylation profile of human spermatozoa during aging.
Results: We used a high throughput, customized methylC-capture sequencing (MCC-seq) approach to characterize
the dynamic DNA methylation in spermatozoa from 94 fertile and infertile men, who were categorized as young, 48
men between 18–38 years or old 46 men between 46–71 years. We identified more than 150,000 age-related CpG
sites that are significantly differentially methylated among 2.65 million CpG sites covered. We conducted machine
learning using our dataset to predict the methylation age of subjects; the age prediction accuracy based on our assay
provided a more accurate prediction than that using the 450 K chip approach. In addition, we found that there are
more hypermethylated (62%) than hypomethylated (38%) CpG sites in sperm of aged men, corresponding to 798 of
total differential methylated regions (DMRs), of which 483 are hypermethylated regions (HyperDMR), and 315 hypomethylated regions (HypoDMR). Moreover, the distribution of age-related hyper- and hypomethylated CpGs in sperm
is not random; the CpG sites that were hypermethylated with advanced age were frequently located in the distal
region to genes, whereas hypomethylated sites were near to gene transcription start sites (TSS). We identified a high
density of age-associated CpG changes in chromosomes 4 and 16, particularly HyperDMRs with localized clusters,
the chr4 DMR cluster overlaps PGC1α locus, a protein involved in metabolic aging and the chr16 DMR cluster overlaps RBFOX1 locus, a gene implicated in neurodevelopmental disease. Gene ontology analysis revealed that the most
affected genes by age were associated with development, neuron projection, differentiation and recognition, and
behaviour, suggesting a potential link to the higher risk of neurodevelopmental disorders in children of aged fathers.
Conclusion: We identified thousands of age-related and sperm-specific epigenetic alterations. These findings
provide novel insight in understanding human sperm DNA methylation dynamics during paternal aging, and the
subsequently affected genes potentially related to diseases in offspring.
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Background
The current trend in fathering children at an older age has
raised concerns due to the reported association between
advanced paternal age and increased incidence of several
conditions including bipolar disorders, attention deficit
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hyperactivity disorder (ADHD), and schizophrenia [1].
However, the influence of paternal age on alterations
in paternal sperm chromatin is still very limited [2, 3].
Spermatogenesis is a life-long process, and the number
of spermatogonial cell divisions prior to spermiogenesis
increases from 35 at puberty to more than 600 at 50 years
of age [4]. Genetic mutations occur during each replication cycle every 2–3 weeks; the mutational load continuously increases in the sperm of older males [4–6]. In
addition to spontaneous genetic mutations during cell
division, the epigenetic modifications must be copied to
the daughter cells, and copying of the epigenetic information is much more error-prone than DNA replication [7].
The epigenome is an essential and modifiable set of serial
marks including DNA methylation, histone posttranslational modifications and small noncoding RNAs. Agedependent modifications of the germ cells epigenome
remain relatively poorly understood.
DNA methylation is a heritable epigenetic modification of cytosine residues within CpG dinucleotides.
Among 28 million CpG sites throughout the mammalian genome, approximately 60–80% are methylated,
displaying relatively stable DNA methylation patterns in
most cell types, except germ cells and pre-implantation
embryos [8]. Using a mouse model, Xie et al. identified
reduced DNA methylation and differentially methylated
promoters in aged sperm, and demonstrated that epigenetic alterations in longevity regulators, reduced life
span and more pronounced aging-associated pathologies
in offspring of animals sired by old father than by young
ones [9]. The relationship between aging and DNA methylation has been studied previously in many human cell
types as well as several tissues [10]. Genome-wide methylation studies have revealed that the sperm epigenome
differs remarkably from that of somatic cells [8, 11]; a
unique state of DNA methylation exists outside of CpG
island sequences in mouse sperm DNA [11, 12]. Human
sperm DNA methylation is quite distinct from that in all
somatic cells and tissues [13]. Earlier studies on sperm
DNA methylation were mostly focussed on imprinted
loci [14–16]. Only a few studies have examined DNA
methylation in human sperm on a genome-wide basis
[17–20].
Using the Infinium Human Methylation 450 Bead
Chip microarray (450 K), Jenkins et al. have identified
139 regions that are significantly and consistently hypomethylated with age and 8 regions that are significantly
hypermethylated with age in human sperm. In addition,
a total of 117 genes that are associated with these regions
of altered methylation were identified [21]. This research
group has also conducted experiments to develop a
sperm DNA methylation-based age predicting calculator [22]; their model was able to predict an individual’s
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chronological age with up to 94% accuracy in comparison with a previously constructed age calculator based
on methylation data from somatic tissues [23]. More
recently, Denomme et al. applied reduced representation bisulfite sequencing (RRBS) to measure the DNA
methylation profiles in sperm of six young (≤ 35 years)
and six older men (≥ 50 years), identified 49,792 differentially methylated CpG sites (DMCs) at nominal p value
or p < 0.05 (corresponded to 3,405 sperm differentially
methylated regions (DMRs)). They found that methylation alterations are not randomly distributed across the
genome and have some links with neurodevelopmental
relevant diseases [24]. Despite those recent advances, the
information of age-associated sperm DNA methylation is
still limited.
Over the past decade, several methods have been
developed and applied to characterize DNA methylation
at gene-specific loci using either traditional bisulfitePCR analysis or pyrosequencing [14, 15], or to determine
genome-wide distribution using microarray analysis, and
RRBS analysis [19]. Although whole genome bisulfite
sequencing (WGBS) provides comprehensive coverage
of the epigenome [25], it highlights a general inefficiency
as 70–80% of the sequencing reads across the in-depth
analysis datasets provide little or no relevant information about CpG methylation sites [8]. A commonly used
approach to examine human sperm DNA methylation
is the 450 K or more recently the Illumina EPIC array
chips [21, 26–28]. However, these arrays provide limited
coverage of the epigenome, are biased toward genic and
CpG-rich regions, and are not specific for the sperm epigenome. MethylC-capture sequencing (MCC-seq) was
developed for targeted assessment of DNA methylation
in a tissue-specific manner [29], and further customized
to target human sperm epigenome with enrichment of
sequences of interest in both genic and intergenic regions
[20].
The objective of the present study was to identify
changes in human sperm DNA methylome as a function
of paternal age and fertility status using our previously
characterized sperm capture panel [20] in order to enrich
bisulfite sequencing coverage to regions of variable and/
or dynamic DNA methylation. We also included analyses of the relationship between paternal age and fertility status with total serum and bioavailable testosterone
concentrations, serum FSH level, high density lipoprotein (HDL), and metabolic parameters as well as smoking. Using high throughput and customized MCC-seq
technique, we identified thousands of age-related epigenomic alterations in human sperm; we also conducted
a machine learning model using our dataset to predict
the methylation age of subjects. Our results provide new
insights on how paternal aging and fertility status interact
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on an array of male reproductive endpoints and demonstrate novel aspects of how aging modifies the sperm
methylation pattern.

Results
Subjects descriptions in MCC‑seq study cohort

Basic characteristics of subjects in this study are shown
in Table 1. Two subpopulations of young (< 40 years,
with mean = 29 years) and old (≥ 40 years, with
mean = 53 years) subjects were used. Within each group,
the fertile control and infertile subjects were matched
(except two fewer patients in the infertile group for old
group). We compared the general semen parameters,
plasma hormone level and key metabolic factors between
the two populations. We observed marginally significant changes for sperm motility (49 ± 3% vs. 38 ± 3%,
p = 0.029) and a significant difference in follicle stimulating hormone (FSH) with lower level in young subjects
(4.09 ± 0.29) compared with old subjects (6.25 ± 0.4,
p = 3.66E−05). We also observed a higher level of testosterone in young subjects than in old ones (11.9 ± 0.6
vs. 9.29 ± 0.52, p = 0.001). No differences were found in
sperm concentrations, or concentrations of luteinizing hormone (LH), thyroid stimulating hormone (TSH),

bioavailable testosterone, total cholesterol, triglycerides,
high density lipoprotein (HDL), low density lipoprotein (LDL), cholesterol/HDL risk ratio, body mass index
(BMI) and tobacco consumption between young and old
groups (Table 1).
Correlations analysis between the age of subjects
and clinical indices in both fertile and infertile men

The relationships between the age of subjects and clinical
indices in both fertile and infertile subjects as assessed
by Pearson correlation analyses are shown in Additional file 1: Table S1. In fertile men, there were significant positive correlations between the age of the subjects
and plasma FSH level, and metabolic parameters such as
BMI, plasma triglycerides, and the risk ratio of total cholesterol to HDL. In addition, there were significant negative correlations between the age of subjects and plasma
total testosterone and bioavailable testosterone concentrations and high density lipoprotein (HDL). However,
in the infertile group many of the correlations were lost;
we only found significant negative correlations between
the age of subjects and sperm motility, and plasma bioavailable testosterone concentrations (Additional file 1:
Table S1).

Table 1 Clinical characterisation of subjects in the MCC-Seq study cohort
Parameter

Age (years)
Sperm concentrations (× 106/ml)
Motility (rapid & slow %)
2

BMI (kg/m )
FSH (IUs/L)
LH (IUs/L)
TSH (mIU/L)
E2RP (qmol/L)
Testosterone (T, nmol/L)
Bioavailable T (nmol/L)
Total cholesterol (mmol/L)
Triglycerides (mmol/L)
HDL (mmpl)/L
LDL (mmol/L)
Cholesterol/HDL risk ratio
Smoking

Young

Old

(mean ± SEM) (n)

(mean ± SEM) (n)

29.38 ± 0.91 (48)

53.15 ± 0.98 (46)

2.04E−31

118.57 ± 15.99 (48)

143.6 ± 18.31 (46)

0.306

26.45 ± 0.99 (48)

28.94 ± 0.85 (46)

0.059

4.34 ± 0.32 (45)

0.108

138.24 ± 8.42 (34)

0.535

5.01 ± 0.61 (43)

0.051

2.89 ± 0.74 (45)

0.202

5.68 ± 2.28 (39)

0.265

48.96 ± 3.26 (48)
4.09 ± 0.29 (48)
3.75 ± 0.17 (48)

2.05 ± 0.34 (47)

130.97 ± 8.06 (34)
11.9 ± 0.6 (48)

6.33 ± 0.27 (48)

5.21 ± 0.79 (48)

1.83 ± 0.37 (48)

2.58 ± 1.35 (48)

3.05 ± 0.51 (47)
3.9 ± 0.2 (47)
N (%)

38.77 ± 3.26 (46)

0.029

6.25 ± 0.4 (45)

3.66E−05

1.84 ± 0.21 (42)

0.591

9.29 ± 0.52 (45)

0.001

5.06 ± 0.44 (45)

0.863

1.87 ± 0.51 (44)

0.624

4.06 ± 0.17 (43)

0.544

N (%)

0.933
(χ2 = 0.138)

Never

29 (61.7%)

28 (61%)

Past

13 (27.7%)

12 (26%)

Current

5 (10.6%)

6 (13%)

NA

1

Values are shown as the mean ± SEM

p values

BMI body mass index, FSH follicle stimulating hormone, LH luteinizing hormone, TSH thyroid stimulating hormone, HDL high density lipoprotein, LDL low density
lipoprotein
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Sperm sample purity as assessed by bisulfite
pyrosequencing analysis of imprinted loci

Prior to MCC-seq, we screened sperm DNA sample
purity by performing bisulfite pyrosequencing of two
paternally methylated gene loci H19 and DLK1/GTL2-IG
DMR, and two maternally methylated gene loci MEST,
KCNQ1OT1. Somatic cell contaminated sperm samples
were excluded for further analysis if the aberrant DNA
methylation was found. As expected, the DNA methylation profile of those imprinted gene loci obtained from
MCC-seq is normal at the QC coordinates at imprinted
loci and in turn confirmed our sample purity (Additional
file 5: Figure S1).
MCC‑seq detects thousands of novel CpGs associated
with sperm aging

We utilized our previously characterized sperm capture panel [20] to enrich bisulphite sequencing coverage to regions variable in human sperm. We targeted
20–30 × coverage of each (n = 94) donor sample. A minimum 20 × coverage for CpG inclusion in association
testing in each and included each targeted CpG with at
least 30 samples having data; we note that 80% of targeted CpGs were detected in at least 90% of samples.
We initially applied a linear model without covariates
and tested association for both fertility and age at 2.65
million passing CpGs. We observed some inflation for
statistically significant differences in methylation upon

aging genomic control inflation, GCin = 1.7 [30], and
less marked statistical inflation for fertility (GCin = 1.39)
(Additional file 5: Figure S2). Applying multiple testing
correction (q-value, qv < 0.01) no significant CpGs were
observed for fertility and > 150,000 significant signals
were found for aging. Using a linear model to perform
the epigenome-wide associations (EWAS) between age
and DNA methylation at 2.65 million passing CpGs with
fertility and other age-associated phenotypes (e.g. lipids,
BMI, etc., see Methods) as covariates. To this end, after
applying multiple testing correction, we observed 21,971
CpGs (q value, qv < 0.01) associated with aging with a
modest genomic inflation (Gin = 1.44) (Fig. 1, Table 2).
Specificity of sperm age‑associated CpGs

Since we detected an order-of-magnitude higher number of CpGs associated with sperm aging, we sought to
explore their specificity using MCC-seq measured CpGs
mapped (n = 908) to the 50 genomic regions listed to
harbor sperm aging CpGs in a previous study [22]. We
observed 116/908 CpGs in 26 of the 50 reported regions
reaching qv < 0.01 (417/908 reaching nominal significance p < 0.05) for sperm age association. In contrast, for
blood aging CpGs [23], we observe only 2 of 307 CpGs
for sperm aging at qv < 0.01 (Fig. 2). This tissue restricted
20-fold enrichment of multiple testing corrected associations in our data among previously suggested
sperm methylation age signature regions yields strong

Fig. 1 Sperm age EWAS results. a CpG—Age association tests QQ-plot shows moderate inflation (GCin = 1.44), and b genome-wide abundance of
CpGs (> 20 K) passing qv < 0.01 significance threshold

Table 2 Age-associated hypo- and hypermethylated CpGs
Age qv < 0.01 novel

Age qv < 0.01 in sperm age loci

All CpGs

Hypermethylated

Hypomethylated

Hypermethylated

Hypomethylated

2599141

13556

8299

6

110
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Fig. 2 Sperm age associations from MCC-seq are specific. CpG association results for sperm aging intervals reported earlier are shown in green
with earlier blood associated CpGs highlighted in red. Only two blood methylation age predicting CpGs reach qv < 0.01, whereas > 100 CpGs in 50
regions are showing significance for sperm methylation age

replication and underscores high specificity of our association; this reiterates the uniqueness for sperm methylation aging as compared to other tissues.
Notwithstanding the strong replication of earlier
results, it is intriguing that most of our genome-wide-significant CpGs (> 99.5%) lie in regions not reported previously. We note that only 4.7% of the CpGs associated
with aging in our dataset are actually represented on the
Illumina 450 K microarray, explaining much of the new
discovery stemming from the “dynamic sperm methylome” we specifically targeted by the capture methylome
assay [20]. Overall, our results suggest pervasive influence of aging in shaping sperm methylome patterns.
Chronological age prediction from sperm MCC‑seq

Next, we explored the prediction of age from sperm
methylome patterns. Due to limited training dataset, we
trained our models using leave-one-out cross-validation
(LOOCV) strategy. That is, each time we leave one sample out and train the model using the remaining samples,
and then predict the age for the leave-out sample. The
procedure was repeated for each sample. In order to test
independence from previously reported sperm age predictor [22], we fetched 450 K CpGs located with Jenkins’
reported sperm aging regions from our sequenced MCCSeq data (published 450 K sites). By taking advantage of
our large panel of MCC-Seq data, we separately trained
a model with top 5 K DMCs (> 99% novel age-associated

CpGs) detected in the LM age model. In all these cases,
the CpGs measured by all samples were eventually used,
i.e. CpGs with missing data were removed for training.
Finally, as an independent test (replication), we tested our
novel sperm age predictor on a recently published sperm
cohort [20] where the sperm age predictor was retrained
by considering the CpGs measured in all training set (94
samples) and testing set (12 samples). As shown in Fig. 3,
the predictor based on novel sites was most accurate
with an average error of 2.68 years (years) (Fig. 3a), and,
even with limited training set, the replication shows age
prediction accuracy with 4.43 year error in the small set
of independent samples (n = 12) (Fig. 3b). These results
underscore the widespread age-related changes in sperm
methylome and suggests that age predictors based on
sperm methylome alterations can be further refined.
Characteristics of sperm aging CpGs

We first examined the overall genomic distribution of
the genome-wide significant age-associated CpGs based
on relative hypo and hypermethylation as a function of
age. Hypomethylation was observed to be less common
(~ 38% of significant sites, n = 8409 CpGs) with distribution of CpGs biased strongly towards proximal regulatory
elements as compared to more prevalent (~ 62% of significant sites, n = 13,562 CpGs) hypermethylation upon
aging (Fig. 4a, b). This new observation of predominance
of age-associated hypermethylation is solely driven by
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Fig. 3 Sperm age prediction analysis. a Comparison of age predictor error between model using previously published CpGs detected on Illumina
450 K Human Methylation array (“450 K published CpGs”, orange bars) and the model with top 5000 CpGs (> 99% novel) from our genomewide
aging EWAS (“Best MCC-seq CpGs”, blue bars), which provided higher prediction accuracy. b Replication of the age predictor in 12 independent
samples from our earlier sperm capture methylome study

sperm age-associated regions not detected by Illumina
microarrays [21] (Table 2).
Furthermore, we observe that 26% of age-associated
CpGs were clustered in DMRs where five or more CpGs
in a 500 bp window showed significant association with
either hypomethylation (n = 315 HypoDMRs) or with
hypermethylation (n = 483 HyperDMRs) among the
total 798 DMRs. The DMRs were characterized by showing stronger associations (Fig. 4c) and particularly hyper
DMRs with localized clusters in chromosomes 4 and 16
leading to high density of age CpGs in these loci (Fig. 4d).
Of note, chr4 DMR cluster overlaps with the peroxisome
proliferator-activated receptor (PPAR)-gamma coactivator (PGC)-1α locus, a protein involved in metabolic
aging [31] and chr16 is overlapping RNA binding fox-1
homolog 1 (RBFOX1) gene, implicated in neurodevelopmental disease [32].

The distribution of age‑related hypo‑ or hyper‑methylated
CpGs in sperm is not random

Using the GREAT [33], we then explored the distribution of age-associated hyper- and hypomethylated
CpGs in relation to gene region and to in-chromosome
location. We annotated each CpG to its closest transcription start site (TSS), and found that the age-associated hypomethylation is proximal to genes, whereas
age-associated hypermethylation occupies gene distal regions (Fig. 4a, b). Furthermore, density of hypomethylation is relatively evenly distributed across the
genome. However, overall sex chromosomes are relatively depleted of age-associated CpGs (Additional
file 5: Figure S3). Taken together, our results indicate
that sperm age-related hypo- or hypermethylated CpGs
are not randomly distributed.
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Fig. 4 Distribution of age-associated hypo- and hypermethylated CpGs in relation to gene region and in chromosome. a Age-associated
hypomethylation is proximal to genes, whereas b hypermethylation occupies gene distal regions. We used GREAT (PMID 20436461) analyses to
annotate each CpG to its closeset transcription start site (TSS). c A subset of age-associated CpGs are clustered in differentially methylated regions
(DMRs) showing higher significances than sporadic age-associated CpGs. d Local density of sperm age-associated hypermethylation (red dots)
shows two outlier regions in the genome reaching > 10% density in chr4 and chr16. Density of hypomethylation (green dots) is relatively evenly
distributed across the genome. Overall, sex chromosomes are relatively depleted of age-associated CpGs

Sperm aging CpGs in relations to chromatin states

The divergence of age-associated hypo- vs. hypermethylated CpGs is also clear from relatively lower average
methylation across all samples at age hypomethylated
sites 39% ± 20% vs. 60% ± 16% (average ± SD). Consequently, nearly 50% of age-associated hypomethylation
localized to open chromatin (DNaseI Hypersensitive Site
Master List (125 cell types) from ENCODE/Analysis [34],
whereas only 20% age-related hypermethylated sites overlapped open chromatin in multiple human cell types. In

line with this observation, the chromatin states enriched
strongly for relatively hypermethylated CpGs are strongly
biased towards heterochromatin for all ENCODE cell
lines; representative distribution of hypo/hypermethylated regions in sperm within Human ES cells (H1/ESC)
mapped to chromatin states is shown in Additional file 1:
Table S3. Similarly, we observed an enrichment (32% vs.
9%) of CpGs in hypo-DMRs in human sperm H3K27me3
histone modification regions [35] where developmental
promoter-like regions were reported in human sperm.
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Analysis of the evolutionarily constrained hyper‑
and hypomethylated region

Genomic element rate profiling (GERP) analysis shows
that evolutionarily constraint is similar among hyperand hypomethylated CpGs (Additional file 5: Figure
S4). Particularly, approximately 15% of CpGs lie in
areas showing similar constraint as known functional
elements (GERP ++ score > 1.7) [36]. However, we also
observed regions with high conservation. For example,
a HyperDMR spanning over 20 CpGs was observed at
the evolutionarily constrained region 3′ of PGC1α locus
in chromosome 4 (shown in Fig. 5). Specifically, this
high evolutionarily constraint region is evident by Phylop constraint scores > 4.88 at 3′ end of the transcript
and distal intergenic region, spanned by age-related
hypermethylation where the top CpG within this region
shows large effect size of 0.84 (p = 2.7e−10).
We further studied the DMRs showing significant evolutionary (GERP ++ score > 1.7) constraint (Additional
file 2: Table S4) observing that disease (OMIM) relevant
gene loci were slightly less likely to be found among
constrained HyperDMRs (61/211, or 29%) as compared
to constrained HypoDMRs (39/114 or 34%). However,
among HyperDMRs at disease loci we observed primary neuropsychiatric/neurodevelopmental/neurological traits for 31% (19/61), whereas only 10% (4/39) of
HypoDMRs at disease loci had primary neurological/
neurodevelopmental picture. An example of sperm aging
HyperDMR (chr2:166900333–166900544) is overlapping
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exon 11 of SCN1A, most common genetic cause of epilepsy, intriguingly most de novo mutations arise in the
paternal chromosome [37], but paternal age has not yet
been associated with occurrence of mutations.
Gene networks implicated by age‑associated methylation

The CpG enrichments analyses in GREAT were done to
look for genes linked to relative hypo- or hypermethylation with higher density of CpG associations in ± 1 Mb
for genes than expected by chance (Additional file 3:
Table S5). We performed gene ontology (GO) analyses
and found an enrichment of 420 genes in age-dependent hypoDMRs, and 606 genes in age dependent hyperDMRs. The top 20 terms were listed for hypoDMRs
(Fig. 6a) and hyperDMRs (Fig. 6b); the lists of enriched
genes in hyper- and hypomethylated regions are shown in
Additional file 4: Table S6. Overall, GO analyses revealed
developmental pathways in both hypo- and hypermethylated regions and markedly strong association signals
for pathways associated with the central nervous system
(CNS) including neuron projection, differentiation and
recognition, and behaviour-related terms in hypermethylated regions with age (Fig. 6). It is interesting to note
that pathways associated with spermatogenesis or sperm
function are not identified in this analysis.

Fig. 5 Evolutionarily constrained region 3′ of PGC1α locus in chromosome 4 with cluster of age-induced hypermethylation. Top associated CpG
is highlighted in red. Raw methylation values (0–100%) are shown (tracks with black tick marks) for six samples representing extremes of the age
distribution in our sample set (ages shown on the right). Bottom track shows 100 vertebrates Basewise Conservation by PhyloP (phyloP100wayAll):
high evolutionary constraints are evident by Phylop constraint scores > 4.88 at 3′ end of the transcript and distal intergenic region, spanned by
age-related hypermethylation
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Fig. 6 Gene networks implicated by age-associated methylation. a Gene ontology (GO) analyses of age genes (n = 420) enriched in age dependent
hypomethylated regions. b GO enrichments in for age dependent genes in hypermethylated regions (n = 606)

Weighted gene co‑expression network analysis (WGCNA)
in sperm MCC‑seq

WCGNA is an unsupervised method used to identify clusters (modules) of highly correlated features and
favours a scale-free network clustering pattern [38]. We
have previously utilized this in identifying correlated
CpGs in diseases [39]. We reasoned that the approach
could identify important sets of CpGs, which may not
reach marginal significance in site-wise analyses. We then
performed trait correlation against modules identified
in WGCNA (Additional file 5: Figure S5). We observed
two highly significant module-trait correlations (|AverageCorr|> 0.6) with each linked to age and composed of
hundreds of CpGs and involving > 100 gene loci (Additional file 4: Table S6). These large modules (MEblue
corr = 0.62, p = 2.00E−11 and MEbrown corr = −0.62,
p = 3.00E−11) show GO enrichments to neuronal as well
as developmental processes (Additional file 5: Figure S6)
with moderate overlap (> 15%) to marginally significant
age-associated CpGs. Several other age trait correlated

(|Corr|> 0.3, p < 0.005) modules are driven by fewer CpGs
and protein coding gene loci most of which were not captured by marginal age associations and may represent
important additional loci for aging. In addition, one moderately correlated module (MEtan corr = 0.33, p = 0.001)
was observed with infertility trait and not detected in
pointwise analyses for infertility associations (Additional
file 5: Figure S5, Additional file 4: Table S6). Remarkably,
the infertility associated CpG module is driven strongly
by single chromosome 8 locus (87 of 97 module CpGs),
which is hypermethylated in sperm from infertile men
(Fig. 7a,b). These CpGs are all in the area of 9 kb region
map proximal to testis-selective long-noncoding RNA
(LINC01606) (Fig. 7c).

Discussion
To our knowledge, this is the first study that uses a high
throughput, customized MCC-seq approach to enrich
bisulfite sequencing coverage to regions of variable and/
or dynamic DNA methylation in human spermatozoa
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Fig. 7 WGCNA revealed a hypermethylated CpG module associated with infertility trait in Chromosome 8 locus. a Sperm DNA methylation track
pattern was shown in representative fertile and infertile subjects (their ID and age on the left), the hypermethylated CpG module maps proximal
to a long noncoding RNA, LINC01606. b Mean CpG methylation levels of sperm from fertile (green) and infertile (red) men on chr8, p-values were
shown in blue (fertile vs. infertile). c Gene expression for LINC01606 in different tissues indicated its testis-selective

designed to identify the effects of both increasing paternal age and fertility. In comparison with previously
commonly used methods, the merit of higher resolution is that it allows for the identification of thousands
of age-related and age-specific epigenetic alterations.
In addition, we found that there are more hypermethylated (62%) than hypomethylated (38%) CpG sites during
aging. Interestingly, the hypermethylated CpG sites were
frequently located in the distal region to genes, whereas
hypomethylated sites were often near to gene region.
Furthermore, developmental pathways were enriched
for both age hypo- and hypermethylated subsets; neuron function and behaviour-related genes were markedly
strong and enriched for age hypermethylated regions in
spermatozoa. However, these dynamic DNA methylation
changes during aging remain to be supported by further
experiments using in vivo cell models to detect biological effect on developmental transcription and signaling;
transgenerational persistence of these changes could be
identified in a longitudinal cohort or in multi-generational families.
We demonstrated that age prediction from our data
improved by increasing the number of age-associated
regions from earlier reported loci to thousands of novel
regions. This suggests that by specific targeting of the
full complement of age-associated CpGs and generating
deep sequencing data (improving pointwise accuracy of

methylation data) across this subset of sperm dynamic
methylome could allow for the development of a finetuned sperm epigenome age tool.
Our results clearly show that the identified DNA methylation alterations are age-related and specific to germ
cells. Sperm DNA methylation patterns were evaluated
in 17 fertile donors in a longitudinal study by comparing the sperm methylome of 2 samples collected from
each individual 9–19 years apart; in that study, using the
Illumina 450 K microarray, 139 age-related hypomethylated regions and 8 age-related hypermethylated regions
were identified [21]. In our study (Fig. 2), we found more
than 100 age-associated CpGs in previously reported 50
age DMR regions are reaching significance for sperm
[22], whereas only two age-related CpGs are significant
in blood [23]. This strong replication of previous sperm
aging data along with no signal enrichment for blood
aging provides clear evidence of sensitivity and specificity
of our technology and dataset. Overall, the results suggest that there is a pervasive influence of aging in shaping
the sperm methylome patterns.
Other than examining the effects of aging, we also
investigated whether the fertility status of these subjects
as well as other covariates affected the sperm methylome. Surprisingly, fertility status did not result in significant changes in the DNA methylation pattern. Previous
studies indicated that sperm DNA methylation patterns
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differed significantly with fertility status; > 8500 DMCs
were identified and were proposed to be predictive of
embryo quality after in vitro fertilization (IVF) [26]. The
reasons for the discrepant results between the two studies are not clear. Male infertility is a multi-factorial disorder; infertility of unknown origin accounts for 37–58% of
all cases [40]. Although the fertility status of subjects is
well defined in this study, and the average sperm concentration was reduced significantly in infertile versus fertile
group (Table 1), we did not have severe oligozoospermic
men in this study. It has been reported that moderate or
severe oligozoospermia is often associated with aberrant DNA methylation of imprinted genes, especially in
patient with less than 10 million spermatozoa per ml [41,
42], but the global DNA methylation was normal [14, 43,
44]; this could, in part, explain why we did not find fertility associated DNA methylation alterations in our study
cohort.
Although we do not detect fertility associated DNA
methylation in pointwise analyses in human sperm, we
do observe a moderately correlated CpGs cluster (module) with infertility trait in WGCNA analysis. Specifically,
the infertility associated CpG module is hypermethylated on chromosome 8 locus in sperm from infertile
men, and is located nearby the upstream of LINC01606,
a testis-selective long-noncoding RNA gene. LINC01606
has been shown to be elevated aberrantly and correlated
with metastasis and invasion of gastric cancer, and its
expression level is associated with Wnt/β-catenin signaling pathway activation through the regulation of miR423-5P [45]. There is no evidence yet that LINC01606
plays a role in spermatogenesis or male fertility, but
whether the hypermethylated CpG module is correlated
to this long non-coding RNA gene in infertile men, and
which miRNA species are subsequently regulated by
LINC01606 in human sperm is worth considering for
further study.
The distribution of age-related either hypo- or hypermethylated CpGs in sperm is not random, as age-associated CpGs in DMRs regions are highly significant (Fig. 4).
We identified 798 age-associated DMRs (483 HyperDMRs and 315 HypoDMRs) that are relatively evenly
distributed in comparison with only 147 DMRs (8 HyperDMRs and 139 HypoDMRs) with strong bias toward
hypomethylation regionally that were identified by Jenkins and colleagues [21]. This suggests that the 450 K
array, which has inherent biases with the use of higher
density of probes at promoter or gene dense regions, provides a selective perspective on the impact of aging on
the methylome.
We identified a high density of age-associated CpGs
changes in chromosomes 4 and 16, particularly HyperDMRs with localized clusters. It is interesting to note that
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the chr4 DMR cluster overlaps PGC1α locus, a protein
involved in metabolic aging [31] and that chr16 DMR
cluster overlaps RBFOX1 locus, a gene implicated in neurodevelopmental disease [32]. The latter was also identified within a MEblue module by WGCNA, in which GO
enrichments to neuronal and developmental processes
were shown. PGC1α is a transcription coactivator that is
involved in a wide variety of biological responses including adaptive thermogenesis, mitochondrial biogenesis,
glucose/fatty acid metabolism and heart development.
PGC-1α is a powerful regulator of energy metabolism in
both health and disease [31]; a close relationship exists
among PGC-1α function, insulin sensitivity, and Type 2
diabetes. With aging, a potentially important defect has
been found in the mitochondrial fatty acid oxidation
pathway associated with insulin resistance [46]. RBFOX1
gene has been recently shown to serve as a ‘hub’ in autism
spectrum disorder (ASD) transcriptome networks and in
neurodevelopmental and psychiatric disorder including
intellectual disability (ID), attention deficit hyperactivity
disorder (ADHD) and schizophrenia [32]. While there is
an indication that sperm DNA methylation patterns do
not persist trans-generationally [47], it has been shown
that paternal age effects on sperm FOX1 and KCNA7
methylation can be transmitted to the next generation
[48]. We speculate that age-induced hypermethylation
might be related to PGC-1α dysfunction, at least in part,
resulting in insulin resistance development in children of
aged father, and that RBFOX1 dysfunction is implicated
in the higher risk of mental disorders of children of older
fathers.
Epigenetic clocks, including DNA methylation clocks,
are a novel class of biomarkers of aging; they also appear
to be a robust measure of chronological age in humans,
and reflect the biological age of individual [49]. The best
established epigenetic clocks pioneered by Hovarth [23,
50] combined blood DNA methylation values in selected
sets of CpG sites in order to predict an individual’s age.
Deviation of epigenetic age from chronological age (epigenetic age acceleration) has been shown to be predictive of deleterious health outcomes [51, 52]. The DNA
methylation clock may not only be a measure of age, but
also a regulator of age. In this study, we show a dissociation between methylome changes during aging between
somatic and male germ cells. It remains to be determined
whether the methylation changes found in spermatozoa
during aging will be able to serve as predictors of the pattern of health and disease of men’s progeny.

Conclusions
Using high throughput and customized MCC-seq technique, we identified thousands of novel age-related
epigenomic alterations in human spermatozoa. Our
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results constitute important new insight on human
sperm DNA methylation dynamics during the process
of aging. These findings provide important new leads to
determine how advanced paternal age results in DNA
methylation that may have consequences on the health
of their progeny.

Methods
Subject recruitment and study design

Both fertile and infertile subjects were recruited from
the Men’s Health Clinic at the Royal Victoria Hospital, Montreal, Quebec over the period of January
2016 to December 2018. Research ethics protocol was
approved by McGill University Health Centre (REB#:
Human Subjects Research 15-068-MUH). All the subjects were evaluated by physicians, informed consent
was obtained from all participants, with the assistance
of the research nurse coordinators. Semen samples
were collected by masturbation with at least 3 days
abstinence. Semen parameters including semen volume, sperm count, concentration, and motility were
assessed, according to the WHO guidelines [53]. Samples were aliquoted, frozen and stored at −80 °C until
further analysis. Plasma hormone levels and metabolic
factors were evaluated.
Inclusion criteria for fertile subjects were: (1) over the
age of 18 years; (2) history of natural fecundity; (3) able
to ejaculate by masturbation to provide semen samples.
Exclusion criteria for fertile subjects are: (1) history of
infertility (defined as inability to achieve natural conception with a reproductively health female partner after
one year of unprotected sexual intercourse) at any point
of his life; (2) inability to provide informed consent; (3)
inadequate sperm per ejaculate (total sperm count below
5 × 106 /ml).
Inclusion criteria for infertile subjects were: (1) over
the age of 18 years; (2) history of idiopathic male-factor
infertility (defined above), with or without anomalies in
semen parameters, in the absence of identifiable causes;
(3) ability to ejaculate by masturbation to provide semen
samples.
For both fertile and infertile groups, the following confounding clinical conditions, known to affect spermatozoa, were used as additional exclusion criteria: recent
(< 6 months) infection/inflammation of the genitourinary
tract; history of hypogonadism and metabolic syndrome;
varicoceles; and history of reconstructive surgery of the
male reproductive tract.
In this study, 94 participants were recruited, 48 fertile controls and 46 infertile subjects. Within fertile and
infertile groups, subjects were categorized in young (18–
38 years) and old (46–71 years) groups.
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Extraction of genomic DNA from spermatozoa

Sperm genomic DNA (gDNA) was extracted from 5
to 10 million spermatozoa using QIAamp DNA Mini
Kit (Qiagen #51306, Qiagen Mississauga, ON) according to the manufacturer’s protocols. Prior to proceeding with DNA extraction, sperm were washed using
cold 0.45% NaCl for 3 times at 1500 g, 5 min at 4 °C to
burst somatic cells. Sperm were then pelleted, and prior
to proceeding, a visual inspection of each sample was
done to ensure the absence of potentially contaminating cells. Sperm lysis was done by pipetting sperm pellets with sperm lysis buffer containing 150 mM EDTA,
10 mM Tris and 40 mM DTT, with the addition of 10%
proteinase K (Sigma P4850) and 3.25% of Sarkosyl (30%
N-Lauroylsarcosine sodium salt solution, Sigma 61747),
and incubated at 56 °C for 2 h. Sperm DNA concentrations were quantified using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, Montreal, QC).
Purity of sperm preparation assessment
by pyrosequencing of imprinted gene loci

Determination of the purity of the sperm preparation,
i.e., absence of contaminating somatic cells, was verified by determining DNA methylation levels of CpG
dinucleotides located on the germline DMRs of maternally and paternally imprinted genes using bisulfite
pyrosequencing as previously described [19] with
minor modifications. Briefly, 100–500 ng of sperm
DNA were subjected to bisulfite conversion treatment using the EpiTect Plus DNA Bisulfite Kit (Qiagen
#59124). Pyrosequencing was done and bisulfite converted DNA as template was subject to PCR reaction
using HotStartTAq Master Mix Kit (Qiagen #203443)
and in a GeneAmp PCR System 2400 (Perkin Elmer,
Montreal, QC). Primers were designed using Qiagen
PyroMark Assay Design SW 2.0 for assessment of two
paternally methylated imprinted gene loci H19, DLK/
GLT2 IG-DMR, and two maternally methylated gene
loci MEST, KCNQ10T1. The sequences of PCR primers
and sequencing primers, and the PCR conditions are
provided in Additional file 1: Table S7. Amplicons were
sequenced using the PyroMark Q24 Reagents Kit (Qiagen #970802), the PyroMark Q24 Vacuum Prep Workstation and Instrument (Qiagen, Valencia, CA, USA)
following the manufacturer’s protocol. All samples used
in this study had methylation profiles confirming a lack
of somatic cell contamination. Sperm gDNA samples
(1 µg) were sent to McGill University Genome Centre
and sequencing (subject for Quality Control again prior
to library preparation for MethylC-capture MCC-seq).
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MethylC‑capture sequencing (MCC‑seq)

MCC-seq was done using a dedicated system to enrich
dynamic CpG sites in human sperm as previously
described [20]. WGBS and targeted bisulfite sequencing were done as previously described [29, 54]. The
WGBS libraries were constructed using the KAPA High
Throughput Library Preparation Kit (Roche/KAPA Biosystems) from 1 µg of the sperm DNA spiked with 0.1%
(w/w) unmethylated lambda and pUC19 DNA (Promega). DNA was sonicated (Covaris) and fragments
sizes of 300-400 bp were controlled on a Bioanalyzer
DNA 1000 Chip (Agilent). Following fragmentation,
DNA end repair of double stranded DNA breaks,
3′-end adenylation, adaptor ligation and clean-up steps
were conducted according to KAPA Biosystems’ protocols. The sample was then bisulfite converted using
the Epitect Fast DNA bisulfite kit (Qiagen) following
manufacturer’s protocol. The resulting bisulfite DNA
was quantified with OliGreen (Life Technology) and
amplified with 9–12 PCR cycles using the KAPA HiFi
HotStart Uracil + DNA Polymerase (Roche/KAPA Biosystems) according to suggested protocols. The final
WGBS libraries were purified using Ampure Beads,
validated on Bioanalyzer High Sensitivity DNA Chips
(Agilent) and quantified by PicoGreen (ThermoFisher).
For WGBS libraries the SeqCap Epi Enrichment System protocol (Roche NimbleGen) was used to capture
the regions of interest. Equal amounts of multiplexed
libraries (84 ng of each; 12 samples per capture) were
combined to obtain 1 µg of total input library and
was hybridized to the capture panel at 47 °C for 72 h.
Washing, recovery, PCR amplification of the captured
libraries as well as final purification were conducted as
recommended by the manufacturer. Bioanalyzer High
Sensitivity DNA Chips (Agilent) were used to determine quality, concentration and size distribution of
the final captured libraries. The capture libraries were
sequenced with a 200-cycle S2 kit (100-bp paired end)
on the NovaSeq 6000 following the NovaSeq XP workflow, at a depth of 0.5 lanes per library.
Sequencing data processing

Targeted sperm panel MCC-Seq HiSeq reads were
aligned using the Epigenome Pipeline available from the
DRAGEN Bio-IT platform (Edico Genomics/Illumina).
Specifically, the MCC-Seq paired-end raw reads were
first demultiplexed into FASTQ files using Illumina’s
bcl2Fastq2-2.19.1 software. Reads were then trimmed
for quality (phred33 ≥ 20) and Illumina adapters using
trimgalore v.0.4.2, a wrapper tool around Cutadapt [55]
and FastQC. Then the trimmed reads were aligned, to
the bisulfite-converted GRCh37 reference genome using
DRAGEN EP v2.6.3 or later in paired end mode using
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the directional/Lister methylation protocol presets;
alignments were calculated for both Watson and Crick
strands and the highest quality unique alignment was
retained. A genome-wide cytosine methylation report
was generated by DRAGEN to record counts of methylated and unmethylated cytosines at each cytosine position in the genome. Methylation counts are provided for
the CpG, CHG and CHH cytosine contexts. DNA methylation level of each CpG was calculated by the number
of methylated reads over the total number of sequenced
reads. CpGs that were found to be overlapping with
SNPs (dbSNP 137), the DAC Blacklisted Regions or Duke
Excluded Regions (generated by the ENCODE project)
were removed. CpG sites with less than 20× read coverage were also discarded.
Age prediction analysis

Sperm age predictor for discovery dataset was built using
the R package glmnet [56]. Starting with the top 5000
significant DMCs, CpGs which were covered by all samples in the discovery cohort were selected to build the
predictor. The DNA methylation level was ranged from
0 to 1. Similar to Horvath’s strategy, the alpha parameter
of glmnet was chosen to 0.5 (elastic net regression) and
the lambda value was chosen using leave-one-out crossvalidation (LOOCV) on the training data [23].
Genomic enrichment analyses

We utilized Genomic Regions Enrichment of Annotations Tool (GREAT) [33] to explore general characteristics of CpGs associated with sperm age in a random set of
88,000 CpGs targeted for custom capture and sequencing [20] as background. To characterize gene networks
potentially linked to age-associated CpGs, we fetched
ENSEMBL gene annotations for significantly GREAT
enriched “foreground” regions (as compared to all targeted CpGs). The analysis of enriched gene ontologies
among GREAT significant “foreground” gene regions
was then pursued by selecting genes with significantly
increased density (± 1 Mb) of multiple testing (qv < 0.01)
adjusted hypo- or hypermethylated CpGs as compared to
random (targeted) CpG background. To further identify
the hypo- and hyper-DMC relative density, we calculated
the ratio of DMCs over the total number of CpGs within
1 Mb sliding windows over the genome.
We also performed GO analyses using Metascape
[57] to enrich genes in age dependent hypo- and hypermethylated regions. We investigated the distribution of
chromatin states (ChromHMM from ENCODE data) of
sperm age-related hypo- and hypermethylated CpGs in
human hESC (H1) [34].
Evolutionarily constraint among hypo- and hypermethylated age-CpGs was done using genomic element rate
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profiling (GERP) analysis, and evolutionary constrained
hypo- and hypermethylated DMRs were localized to disease (OMIM) relevant gene loci [58].
Weighted gene‑co‑expression network analysis (WGCNA)

Weighted gene co-expression network analysis
(WGCNA), aimed at detecting highly correlated module of CpGs, was done using 20,000 variable CpGs. The
input CpGs were chosen based on uniform (no missing
values) coverage (i.e. ≥20X) and population variance (i.e.
top 20,000 most variable CpGs based on their variance,
and roughly top 5% of variance) among our samples. The
WGCNA was ran using the WGCNA package in R [38]
with the default parameters. A soft-thresholding power
of 8, which is the lowest power for which the scale-free
topology fit index curve flattens out upon reaching a high
value of signed R-square of 0.9, was chosen. A maximum
block size of 20,000 and unsigned network were used (to
construct a topological overlap matrix) and minimum
number of CpGs per module = 30 and cut height = 0.4
were used to detect methylation modules. The module
eigengene (ME) value was calculated for each module and
further the Pearson correlation between MEs and traits
was computed to quantify module-trait associations.
The CpGs from significant module trait correlations
(p < 0.005, absolute correction |Corr|> 0.3) were used as
input to GREAT protein coding gene enrichment using
top 20 K variable CpGs as above. For the top 2 most complex modules involving 100 genes, we further performed
GO enrichment analyses.
Statistical analyses

Statistical analyses for the characterization of subjects
were done using GraphPad Prism 6 Software (San Diego,
CA). Comparisons of semen parameters, biochemical
and metabolic factors between fertile and infertile subjects were done using Student’s t-test. Pearson correlations were used for age and other semen parameters and
metabolic factors. p < 0.05 was considered statistically
significant.
Linear regression models (LMs) were built to investigate the association between the DNA methylation
level (methylation proportion defined above) and age.
The age LM model was adjusted by correcting infertility status, sperm concentration, smoking status, and
other clinic indices such as total testosterone, bioavailable testosterone concentrations, plasma FSH level,
high density lipoprotein (HDL), and other metabolic
parameters including BMI, plasma triglycerides and the
risk ratio of total cholesterol to HDL. We used the R
function lm() to fit the models, and calculated p-values
for variables of interest. QQ-plot and Manhattan plot
were reported for each LM. We further evaluated the
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obtained p-values by generating false discovery proportion q-values using the R package q-values [59].
We reported qv < 0.01 as the genome-wide significant
DMCs. The detailed number of CpGs used in each
model is listed in Additional file 1: Table S2.
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